21.07
Schlusskurs vom Vortag:
$21.31
Offen:
$21.34
24-Stunden-Volumen:
2.47M
Relative Volume:
0.31
Marktkapitalisierung:
$8.47B
Einnahmen:
$12.84B
Nettoeinkommen (Verlust:
$255.20M
KGV:
34.99
EPS:
0.6024
Netto-Cashflow:
$584.50M
1W Leistung:
+11.21%
1M Leistung:
+0.79%
6M Leistung:
-21.86%
1J Leistung:
-44.70%
Chewy Inc Stock (CHWY) Company Profile
Firmenname
Chewy Inc
Sektor
Branche
Telefon
786-320-7111
Adresse
7700 WEST SUNRISE BOULEVARD, PLANTATION, FL
Compare CHWY vs AMZN, BABA, PDD, MELI, DASH
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
CHWY
Chewy Inc
|
21.07 | 8.47B | 12.84B | 255.20M | 584.50M | 0.6024 |
|
AMZN
Amazon Com Inc
|
251.98 | 2.72T | 742.78B | 90.80B | -2.47B | 8.3676 |
|
BABA
Alibaba Group Holding Ltd Adr
|
109.93 | 273.48B | 144.18B | 14.66B | -7.14B | 6.1924 |
|
PDD
Pdd Holdings Inc Adr
|
81.78 | 116.41B | 62.32B | 13.62B | 15.10B | 9.1742 |
|
MELI
Mercadolibre Inc
|
1,836.66 | 93.11B | 31.80B | 1.92B | 8.56B | 37.87 |
|
DASH
Doordash Inc
|
191.38 | 82.92B | 14.72B | 923.00M | 1.75B | 2.0994 |
Chewy Inc Stock (CHWY) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-09-11 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2026-09-10 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2026-08-20 | Eingeleitet | Rosenblatt | Neutral |
| 2026-06-11 | Herabstufung | MoffettNathanson | Buy → Neutral |
| 2026-02-19 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2025-09-25 | Hochstufung | MoffettNathanson | Neutral → Buy |
| 2025-09-11 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2025-09-11 | Hochstufung | Seaport Research Partners | Neutral → Buy |
| 2025-09-08 | Hochstufung | Mizuho | Neutral → Outperform |
| 2025-07-10 | Fortgesetzt | Citizens JMP | Mkt Outperform |
| 2025-06-09 | Herabstufung | Mizuho | Outperform → Neutral |
| 2025-06-05 | Herabstufung | Jefferies | Buy → Hold |
| 2025-03-24 | Eingeleitet | Seaport Research Partners | Neutral |
| 2025-01-23 | Hochstufung | Argus | Hold → Buy |
| 2025-01-13 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2025-01-06 | Hochstufung | Mizuho | Neutral → Outperform |
| 2025-01-03 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2024-12-05 | Herabstufung | Exane BNP Paribas | Outperform → Neutral |
| 2024-11-20 | Hochstufung | BofA Securities | Underperform → Buy |
| 2024-11-08 | Hochstufung | Citigroup | Neutral → Buy |
| 2024-10-23 | Fortgesetzt | Needham | Hold |
| 2024-10-09 | Eingeleitet | TD Cowen | Buy |
| 2024-08-23 | Fortgesetzt | Piper Sandler | Overweight |
| 2024-08-21 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2024-07-16 | Eingeleitet | Wolfe Research | Peer Perform |
| 2024-07-09 | Herabstufung | Argus | Buy → Hold |
| 2024-03-19 | Eingeleitet | Mizuho | Neutral |
| 2024-01-11 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2024-01-10 | Fortgesetzt | Goldman | Buy |
| 2023-12-19 | Eingeleitet | Jefferies | Buy |
| 2023-10-31 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2023-10-25 | Hochstufung | UBS | Sell → Neutral |
| 2023-10-19 | Fortgesetzt | BofA Securities | Underperform |
| 2023-09-20 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2023-09-06 | Hochstufung | Argus | Hold → Buy |
| 2023-09-01 | Bestätigt | Guggenheim | Buy |
| 2023-08-31 | Bestätigt | Barclays | Equal Weight |
| 2023-08-31 | Bestätigt | Citigroup | Neutral |
| 2023-08-31 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2023-08-31 | Bestätigt | JP Morgan | Overweight |
| 2023-08-31 | Bestätigt | Morgan Stanley | Equal-Weight |
| 2023-08-31 | Bestätigt | Needham | Buy |
| 2023-08-31 | Bestätigt | Oppenheimer | Outperform |
| 2023-08-31 | Bestätigt | Piper Sandler | Neutral |
| 2023-08-31 | Bestätigt | RBC Capital Mkts | Outperform |
| 2023-08-31 | Bestätigt | Robert W. Baird | Outperform |
| 2023-08-31 | Bestätigt | UBS | Sell |
| 2023-08-25 | Bestätigt | Wedbush | Outperform |
| 2023-07-17 | Hochstufung | Goldman | Neutral → Buy |
| 2023-06-01 | Hochstufung | Gordon Haskett | Hold → Buy |
| 2023-05-03 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2023-04-19 | Eingeleitet | Argus | Hold |
| 2023-04-11 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2023-03-23 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2023-03-10 | Eingeleitet | ROTH MKM | Buy |
| 2023-02-15 | Eingeleitet | Gordon Haskett | Hold |
| 2023-01-27 | Hochstufung | Wedbush | Neutral → Outperform |
| 2022-12-07 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2022-11-15 | Eingeleitet | MoffettNathanson | Market Perform |
| 2022-10-07 | Eingeleitet | Oppenheimer | Outperform |
| 2022-07-26 | Herabstufung | Wedbush | Outperform → Neutral |
| 2022-06-27 | Hochstufung | Needham | Hold → Buy |
| 2022-06-21 | Hochstufung | Wedbush | Neutral → Outperform |
| 2022-03-11 | Eingeleitet | Deutsche Bank | Buy |
| 2022-01-28 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2022-01-07 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2021-12-16 | Bestätigt | Citigroup | Neutral |
| 2021-12-13 | Bestätigt | Piper Sandler | Overweight |
| 2021-12-10 | Bestätigt | Barclays | Equal Weight |
| 2021-12-10 | Bestätigt | JP Morgan | Overweight |
| 2021-12-10 | Bestätigt | Jefferies | Buy |
| 2021-12-10 | Bestätigt | Morgan Stanley | Equal-Weight |
| 2021-12-10 | Bestätigt | UBS | Sell |
| 2021-12-10 | Bestätigt | Wells Fargo | Overweight |
| 2021-12-06 | Herabstufung | Wedbush | Outperform → Neutral |
| 2021-09-28 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2021-09-27 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-09-13 | Eingeleitet | Goldman | Neutral |
| 2021-09-02 | Bestätigt | Barclays | Equal Weight |
| 2021-09-02 | Bestätigt | Jefferies | Buy |
| 2021-09-02 | Bestätigt | Morgan Stanley | Equal-Weight |
| 2021-08-05 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-07-28 | Eingeleitet | Robert W. Baird | Outperform |
| 2021-07-16 | Eingeleitet | Exane BNP Paribas | Outperform |
| 2021-07-08 | Eingeleitet | Needham | Hold |
| 2021-05-03 | Eingeleitet | Guggenheim | Buy |
| 2021-04-06 | Fortgesetzt | Evercore ISI | Outperform |
| 2021-04-01 | Eingeleitet | Wolfe Research | Peer Perform |
| 2021-03-09 | Eingeleitet | Citigroup | Neutral |
| 2021-01-19 | Herabstufung | UBS | Neutral → Sell |
| 2021-01-13 | Bestätigt | Credit Suisse | Outperform |
| 2020-12-17 | Bestätigt | Needham | Buy |
| 2020-11-13 | Eingeleitet | Piper Sandler | Overweight |
| 2020-10-16 | Hochstufung | Jefferies | Hold → Buy |
| 2020-09-11 | Bestätigt | Barclays | Equal Weight |
| 2020-09-11 | Bestätigt | Credit Suisse | Outperform |
| 2020-09-11 | Bestätigt | Jefferies | Hold |
| 2020-09-11 | Bestätigt | Morgan Stanley | Equal-Weight |
| 2020-09-11 | Bestätigt | RBC Capital Mkts | Outperform |
| 2020-09-08 | Bestätigt | Barclays | Equal Weight |
| 2020-08-28 | Bestätigt | Wells Fargo | Overweight |
| 2020-07-15 | Eingeleitet | Cleveland Research | Buy |
| 2020-06-22 | Bestätigt | Morgan Stanley | Equal-Weight |
| 2020-06-10 | Bestätigt | Barclays | Equal Weight |
| 2020-06-10 | Bestätigt | BofA/Merrill | Buy |
| 2020-06-10 | Bestätigt | Credit Suisse | Outperform |
| 2020-06-10 | Bestätigt | JP Morgan | Overweight |
| 2020-06-10 | Bestätigt | Nomura | Buy |
| 2020-06-10 | Bestätigt | RBC Capital Mkts | Outperform |
| 2020-06-10 | Bestätigt | UBS | Neutral |
| 2020-06-10 | Bestätigt | Wedbush | Outperform |
Alle ansehen
Chewy Inc Aktie (CHWY) Neueste Nachrichten
Chewy vs. MercadoLibre: Which E-Commerce Stock Is a Better Buy in 2026? - The Motley Fool
Chewy: Gaining Share In A Tough Market - Seeking Alpha
Chewy (CHWY) Down 10.3% Since Last Earnings Report: Can It Rebound? - Zacks Investment Research
A Look at Chewy Inc (CHWY) After 3.8% Gain -- GF Value $31.39 vs Price $18.91 - GuruFocus
Chewy lowers the subscription price of its membership program (CHWY:NYSE) - Seeking Alpha
Chewy, Inc. (CHWY) Stock Forecasts - Yahoo! Finance Canada
Chewy, Inc. (CHWY) Stock forecasts - Yahoo Finance UK
Chewy, Inc. (CHWY) Stock forecasts - Yahoo Finance UK
Chewy (CHWY) Q3 2025 Earnings: Results, Market Reaction & History - 24/7 Wall St.
Chewy, Inc. (CHWY) Stock Forecasts - Yahoo Finance
Chewy, Inc. (CHWY) Stock Forecasts - Yahoo Finance
Chewy (CHWY) Q4 2024 Earnings: Results, Market Reaction & History - 24/7 Wall St.
Chewy’s Expanding Pet Healthcare Ecosystem Fortifies Its Narrow Moat and Deepens Customer Engagement - Morningstar
Chewy, Inc. (CHWY) Stock Forecasts - Yahoo! Finance Canada
Long term debt to total equity ratio of Chewy, Inc. Class A – HAN:3HH - TradingView
Chewy's Vet Care Posts Triple-Digit Growth as Clinic Scale Builds - Zacks Investment Research
Chewy's Vet Care Posts Triple-Digit Growth as Clinic Scale Builds - TradingView
Chewy's Vet Care Posts Triple-Digit Growth as Clinic Scale Builds - es.tradingview.com
Chewy's Vet Care Posts Triple-Digit Growth as Clinic Scale Builds - Yahoo Finance
Chewy (NYSE:CHWY) Given New $28.00 Price Target at Mizuho - MarketBeat
Chewy, Inc. (CHWY) Stock Forecasts - Yahoo! Finance Canada
Chewy, Inc. (CHWY) Options ChainYahoo Finance - ca.finance.yahoo.com
Chewy, Inc. (CHWY) Options ChainYahoo Finance - Yahoo! Finance Canada
Chewy, Inc. (CHWY) Options ChainYahoo Finance - Yahoo! Finance Canada
Chewy (CHWY) Stock Fair Value Moves Lower As Analysts Reassess Growth And Spending - Yahoo Finance
What's Driving the Buzz Around Chewy, Inc. (CHWY) in Consumer Stocks? - Kalkine Media
Chewy (CHWY) Files A Shelf Registration, Is The Stock Still Cheap? - Yahoo Finance
Chewy Stock Falls 24.9% in a Month as Risks Challenge Growth Momentum - The Globe and Mail
Can Autoship and Health Growth Support Chewy Stock's Valuation? - The Globe and Mail
Cat People vs. Dog People: Chewy’s CEO Reveals Who’s Spending More on Their Pets Right Now, and Who’s Cutting Back - Yahoo Finance
Chewy's Q2 Growth and AI Savings Lift Its 2026 Outlook Higher - TradingView
Can Autoship and Health Growth Support Chewy Stock's Valuation? - TradingView
Chewy Stock Falls 24.9% in a Month as Risks Challenge Growth Momentum - Yahoo Finance
Chewy's Q2 Growth and AI Savings Lift Its 2026 Outlook Higher - Yahoo Finance
Can Autoship and Health Growth Support Chewy Stock's Valuation? - Yahoo Finance
Chewy (CHWY) vs. Petco (WOOF): Proven Growth Story or Turnaround Bet? - Insider Monkey
Chewy (CHWY) vs. Petco (WOOF): Proven Growth Story or Turnaround Bet? - Yahoo Finance
Chewy Inc (CHWY) Shares Fall 4.1% -- What GF Score of 70 Tells I - GuruFocus
Chewy (NYSE:CHWY) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
Chewy, Inc. (3HH.F) Analyst insights, Price targets and RecommendationsYahoo Finance - Yahoo Finance Singapore
Chewy vs. Uber Technologies: Which Consumer Stock Is a Better Buy in 2026? - The Motley Fool
Chewy (CHWY) Beats on Profit Even as Pet Spending Stays Soft - finance.yahoo.com
Tranche Update on Chewy, Inc.'s Equity Buyback Plan announced on May 29, 2024. - marketscreener.com
Chewy Veterinary Clinic Makes Northwest Debut in Redmond - 425business.com
Chewy (CHWY) Files Shelf Registration To Keep Future Funding Options Open - Yahoo Finance
Is Chewy’s (CHWY) Margin Story Losing Steam, or Is a 48% Drop the Opportunity? - finance.yahoo.com
US dog supplements sold on Amazon, Chewy recalled over salmonella risk to pets, owners - Yahoo
Chewy vs. MercadoLibre: Which E-Commerce Stock Is a Better Buy in 2026? - Yahoo Finance
Morgan Stanley delivers blunt message to America’s pet owners - thestreet.com
These Analysts Revise Their Forecasts On Chewy Following Q2 Results - webull.com
Finanzdaten der Chewy Inc-Aktie (CHWY)
Umsatz
Nettogewinn
Free Cashflow
ENV
Chewy Inc-Aktie (CHWY) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Singh Sumit | Officer |
Aug 03 '26 |
Proposed Sale |
23.01 |
43,244 |
995,044 |
0 |
| Singh Sumit | Member of immediate family of |
Aug 03 '26 |
Proposed Sale |
23.01 |
6,233 |
143,421 |
0 |
| Singh Sumit | Chief Executive Officer |
Aug 03 '26 |
Sale |
23.01 |
6,233 |
143,421 |
125,404 |
| Singh Sumit | Chief Executive Officer |
Aug 03 '26 |
Sale |
23.01 |
43,244 |
995,044 |
886,630 |
| Hu Da-Wai | Officer |
Jun 29 '26 |
Proposed Sale |
19.49 |
4,203 |
81,915 |
0 |
| Hu Da-Wai | General Counsel & Secretary |
Jun 29 '26 |
Sale |
19.49 |
4,203 |
81,915 |
0 |
| Singh Sumit | Officer |
May 04 '26 |
Proposed Sale |
25.60 |
83,306 |
2,132,634 |
0 |
| Singh Sumit | Chief Executive Officer |
May 04 '26 |
Sale |
25.60 |
83,306 |
2,132,634 |
874,061 |
| Singh Sumit | Chief Executive Officer |
May 04 '26 |
Sale |
25.60 |
4,220 |
108,032 |
123,955 |
| Singh Sumit | Member of immediate family of |
May 04 '26 |
Proposed Sale |
25.60 |
4,220 |
108,032 |
0 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):